Plans have been revealed today to create 3,000 new jobs on the former Pfizer site in Kent.
The news follows Discovery Park's recent change of ownership in August to a consortium led by chief executive Chris Musgrave and chairman Trevor Cartner.
The 297 acre site currently employs 900 people across 14 companies including Augean, Mylan, Peakdale Chemistry Services, Pfizer and LGC among others.
In the long term, Discovery Park Limited plans to attract new tenants including government scientific bodies, research organisations and science and technology businesses to the site.
They plan to take advantage of the site's Enterprise Zone status and the government funded tax reliefs for science companies as an incentive to attract global brands. They also want to attract universities to the site.
The company say they have a proven track record in delivering similar projects such as Wynyard Park, a 700 acre site in Teesside, north east England, where 65 different companies are based and 2,000 jobs have been created since 2005.
Mr Musgrave said: "We recognised the potential of the site immediately and were confident that we could make a real difference from the outset.
"Over the last fifty years Pfizer has established a long and rich heritage on site, which we are keen to build upon and our plan is to showcase the extraordinary facilities to the global life science, biotechnology, pharmaceutical, science and technology industries, among others.
"To have such a diverse range of services in one location - from laboratories to incubator space, specialist niche manufacturing and R&D facilities to warehouse units - is a unique proposition and one which we believe sets Sandwich apart from its competitors."